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A Case of Spitzoid Melanoma with Lymph Node Metastasis in  
a Child
The distinction of a spitz nevus from a melanoma can be difficult and in some cases, 
impossible. A misdiagnosed spitz nevus can metastasize and lead to fatal outcomes, 
especially in children. A 5-yr-old girl presented with a 1-yr history of a solitary pinkish 
nodule on her left hand. On physical examination, she had a palpable left axillary lymph 
node. We performed biopsy and checked 3 sentinel lymph nodes (SLN) on her axillary area. 
The biopsy specimen showed multiple variably sized and shaped nests with large spindle or 
polygonal cells and SLN biopsy showed 3 of 3 lymph nodes that were metastasized. Under 
the diagnosis of spitzoid melanoma, she was treated with excision biopsy and complete 
left axillary lymph nodes were dissected. She received interferon-α2b subcutaneously at a 
dose of 8 MIU per day, 3 times weekly for 12 months, and shows no recurrence.
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CASE REPORT
Pediatrics
INTRODUCTION
Spitzoid melanoma is a malignant melanoma occurring com-
monly on the head and extremities and shares many histopath-
ologic and clinical features with spitz nevus (1-3). Relative lack 
of reliable pathological criteria for discrimination between be-
nign and malignant melanocytic lesions makes it very difficult 
for clinicians and pathologists to render the ominous diagnosis 
of melanoma, especially combined with the low frequency of 
cutanoeous melanoma in childhood. Cutaneous melanoma in 
children and adolescents (age 0-17 yr) accounted for only 1.3% 
of cases in the USA over the past two decades and only 0.3%-0.4% 
of melanomas are diagnosed for patients younger than 10 yr (3). 
  Clinically, spitzoid melanomas are usually changing amela-
notic nodular lesions which can be crusted and ulcerated. They 
resemble hemangiomas, pyogenic granulomas, xanthograulo-
mas, or basal cell carcinomas (1). Although spitzoid melanomas 
are more common in adults, due to extremely low rates of other 
cutaneous melanoma subtypes in children under the age of       
17 yr, the incidence rate appears disproportionately higher in 
this age group (1, 4, 5). Consequently, there often are spitzoid 
melanomas originally diagnosed as spitz nevi that metastasize 
and lead to fatal outcomes in children (6).
  In the Korean literature, there are no previously reported cas-
es of spitzoid melanoma with lymph node metastasis in children. 
Herein, we report a rare case of spitzoid melanoma in a 5-yr-old 
Korean girl along with the interest on its lymph node metastasis.
CASE DESCRIPTION
On June 15, 2009, a 5-yr-old girl presented with a 1-yr history of 
a slightly tender, solitary pinkish protruding nodule on the dor-
sum of her left hand. The nodule dimensions were 7 × 9 mm 
(Fig. 1) and it would bleed easily with a light touch. Under the 
impression of pyogenic granuloma or spitz nevus, we took 
punch biopy. The histopathologic findings showed multiple 
nests of variable size and irregular shape with large spindle or 
polygonal cells which had amphophilic cytoplasm. Contrary to 
features of a spitz nevus, there were no mature cells from the 
surface to the base and common mitosis in the dermis was ob-
served. The Breslow’s depth was obviously over 4 mm (Fig. 2). 
The immunohistochemical staining showed that Melan-A was 
positive in whole skin level and weakly positive for HMB-45 
(Fig. 3). On the basis of these clinical and histological findings, 
a diagnosis of spitzoid melanoma was made. There was no per-
sonal or family history of melanomas and the patient was oth-
erwise in good health.
  On physical examination, the patient had a palpable left axil-
lary lymph node. The laboratory analysis revealed the patient 
had 442 IU/L of LDH levels in her blood which was within the 
high normal range (50-450 IU/L). Gene analysis using multiplex 
PCR showed negative for B-RAF somatic mutation. Since a pal-
pable left axillary lymph node was present, a metastatic workup 
by chest computed tomography (CT) and positron emission to-
mography/CT (PET/CT) scan was also performed. However, in Kim JY, et al.  •  A Spitzoid Melanoma in a Child
http://jkms.org   455 http://dx.doi.org/10.3346/jkms.2012.27.4.454
these evaluations, there were no specific signs of distant metas-
tasis. We performed excision biopsy with 2 cm free margin and 
repaired the defect with a full thickness skin graft. We checked 3 
sentinel lymph nodes on her left axillary area and found that all 
of them were metastasized. In cooperation with the breast sur-
geons, complete left axillary lymph nodes were dissected, which 
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Fig. 1. Gross view of the skin lesion. (A) Slightly tender, solitary pinkish protruding nodule on the lateral side of the dorsum of her left hand. (B) Dermoscopic photo of lesion.
A B
Fig. 3. Immunohistochemistry of the skin lesion. (A) Melan-A is positive at the whole skin level (Melan-A, × 12.5) and (B) weakly positive for HMB-45 (HMB-45, × 12.5).
A B
Fig. 2. Histopathology of the skin lesion. (A) Abundant irregular nests of different sizes and shapes and asymmetrical proliferation of enlarged atypical epithelioid and spindle 
shaped melanocytes in the deep dermis. No maturation of cells from near the surface to the base (H&E stain, × 40). (B) At high power magnification, atypical epithelioid and 
spindle shaped melanocytes with large, hyperchromatic, pleomorphic nuclei were observed (H&E stain, × 100).Kim JY, et al.  •  A Spitzoid Melanoma in a Child
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showed one of eighteen lymph nodes to be positive (Fig. 4). She 
received interferon-α2b subcutaneously at a dose of 8 MIU per 
day, 3 times weekly for 12 months. She shows no recurrence 
until now, 27 months after surgery. 
DISCUSSION
Pediatric melanoma is somewhat different from adult melano-
ma. It is more likely to have an atypical clinical appearance such 
as amelanotic or pyogenic granuloma-like, like in the present 
case. The nodular subtype is more common in pediatric mela-
noma than adult melanoma (27% vs 15%) and tends to be thicker 
and more frequently metastasizes to sentinel lymph nodes 
(SLN) (7).
  In comparison with spitz nevus, spitzoid melanoma has an 
asymmetric shape with a size usually exceeding 10 mm. Histo-
logically, it showed nests of variable size and shape with large 
spindle or epithelioid cells. Cytologically, the melanocytes have 
large, pleomorphic, hyperchromatic nuclei and prominent ba-
sophilic to eosinophilic nucleoli. Spitzoid melanoma has a higher 
degree of cytologic atypia than spitz nevus (2).
  However, in most cases, these features are not helpful to dis-
tinguish spitzoid melanoma from spitz nevus and therefore, re-
cently there are studies that are trying to use molecular cytoge-
netic analysis for distinction. Bastian et al. (8, 9) demonstrated 
that 80% of spitz nevi with gain of chromosome 11p showed  
increased copy number of an oncogenic HRAS allele. HRAS is 
rarely mutated in malignant melanoma (1, 8, 9). Though the 
detection of B-RAF gene mutation was recently studied, Lee         
et al. (6) have suggested that in contrast to the majority of cuta-
neous melanomas, activating hot-spot mutations in B-RAF or 
N-RAS were not involved in the pathogenesis of spitzoid mela-
noma. In our case, the mutation of B-RAF gene was negative.
  In studies using immunohistochemistry, Ki-67/MIB-1 prolif-
eration index was suggested as a useful marker for distinguish-
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Fig. 4. Immunohistochemistry of the lymph nodes. (A) The biopsy specimen from the axillary lymph node shows positive results for Melan-A (Melan-A, × 12.5). (B) Atypical me-
lanocytes found within the lymph node parenchyma (Melan-A, × 40).
ing spitz nevus from melanoma. Bergman et al. (10) reported 
that the best cutoff value for discriminating was 4.5% in a total 
count of Ki-67/MIB-1 stained epidermal and dermal melano-
cytes. Other study results indicated that the index more than 10% 
favors melanoma and less than 2%, spitz nevus. The index be-
tween 2% and 10% yields various predictive values for spitz   
nevus (11). The Ki-67 proliferation index of the present patient 
was 5%. Although this proliferation index is low value, it is suffi-
cient to meet the cutoff value for melanoma as mentioned by 
Bergman.
  Though the place of SLN biopsy in the management of atypi-
cal spitzoid melanocytic lesions remains uncertain (4), it may 
serve as an adjunct procedure in the evaluation of diagnostical-
ly difficult spitzoid tumors by increasing the sensitivity of the 
diagnosis and providing potentially useful prognostic informa-
tion (3). Several studies reported that SLN biopsy is recommend-
ed for prognostic purposes when malignant melanoma cannot 
be entirely ruled out in such cases as 1 mm or more in Breslow 
thickness and Clark IV or ulcerated lesion even if thinner than  
1 mm (1, 12). However, this needs to be further investigated   
because another study revealed that there were no significant 
differences between SLN-positive and SLN-negative cases with 
regards to histological features (3). One problem is that there is 
another group of spitz tumors that have the potential of spread-
ing to a regional node, but lack the potential for distant metas-
tasis. Also, the benign lesion (spitz nevus cell aggregate of lymph 
node) looks more like a melanoma metastasis than the better-
known nevus cell aggregate of the lymph node (13). In addition, 
some pathologists have cautioned against classifying cutane-
ous melanocytic tumors based on SLN results (14). They point 
out that a lymph node may contain benign tissue foreign to it, 
such as mesothelial cells, mammary epithelium, or Mullerian 
epithelium. Such “benign metastases” have also been suggested 
to explain the occurrence of many nodal melanocytic nevi (14). 
Therefore, Busam et al. (15) suggested that if uncertain about Kim JY, et al.  •  A Spitzoid Melanoma in a Child
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the correct diagnosis, further investigation by comparative         
genomic hybridization or fluorescence in situ hybridization 
studies before SLN biopsy is recommended. With regard to our 
patient, histopathologic and immunohistochemical findings 
suggested strongly for malignant melanoma and axillary lymph 
nodes were palpable, so we performed SLN biopsy and com-
plete lymph node dissection. Totally, 4 of the 21 harvested lymph 
nodes showed atypical melanocytes within the lymph node pa-
renchyma, which implied metastatic malignant melanoma.
  Pol-Rodriguez et al. (5) found 88% 5-yr survival rate in chil-
dren with metastatic spitzoid melanoma between 0 and 10 yr of 
age compared with 49% in those between 11 and 17 yr of age. 
There are recent studies demonstrating that the prognosis of 
children with spitzoid melanoma has been suggested to be bet-
ter than observed in adults, even when they have local metasta-
ses or positive SLNs (1, 13, 14). Though it may at least in part  
reflect the strength of the immune system at a young age, this 
remains controversial (3, 14). It has also been suggested that 
surgical intervention (removal of the positive SLNs) alters the 
biologic behavior of the tumor and thereby permits a more           
favorable clinical course (14).
  In conclusion, this is a rare case of a 5-yr-old child diagnosed 
with metastatic spitzoid melanoma, stage IV (M1a), and there 
has not been any previously reported case in Korean literature. 
The 5-yr survival rate of stage IV (M1a) in conventional cutane-
ous melanoma is 18.8%, but it may be higher in this patient as 
we discussed above. We will follow her up closely for signs of 
regional and distant recurrence.
REFERENCES 
1. Kamino H. Spitzoid melanoma. Clin Dermatol 2009; 27: 545-55.
2. Elder DE, Elenitsas R, Murphy GF, Xu X. Benign pigmented lesions and 
malignant melanoma. In: Elder D, Elenitsas R, Johnson BL Jr, Murphy 
GF, Xu X, editors. Lever’s histopathology of the skin. 10th ed. Philadel-
phia: Lippincott Williams & Wilkins, 2009, p718-24.
3. Paradela S, Fonseca E, Pita S, Kantrow SM, Goncharuk VN, Diwan H, 
Prieto VG. Spitzoid melanoma in children: clinicopathological study 
and application of immunohistochemistry as an adjunct diagnostic 
tool. J Cutan Pathol 2009; 36: 740-52.
4. Barnhill RL, Gupta K. Unusual variants of malignant melanoma. Clin 
Dermatol 2009; 27: 564-87.
5. Pol-Rodriquez M, Lee S, Silvers DN, Celebi JT. Influence of age on sur-
vival in childhood spitzoid melanomas. Cancer 2007; 109: 1579-83.
6. Lee DA, Cohen JA, Twaddell WS, Palacios G, Gill M, Levit E, Halperin 
AJ, Mones J, Busam KJ, Silvers DN, Celebi JT. Are all melanomas the 
same? Spitzoid melanoma is a distinct subtype of melanoma. Cancer 
2006; 106: 907-13.
7. Berk DR, LaBuz E, Dadras SS, Johnson DL, Swetter SM. Melanoma and 
melanocytic tumors of uncertain malignant potential in children, ado-
lescents and young adults: the Stanford experience 1995-2008. Pediatr 
Dermatol 2010; 27: 244-54.
8. Bastian BC, Wesselman U, Pinkel D, Leboit PE. Molecular cytogenetic 
analysis of Spitz nevi shows clear differences to melanoma. J Invest Der-
matol 1999; 113: 1065-9.
9. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increases 
of HRAS in Spitz nevi with distinctive histopathological features. Am J 
Pathol 2000; 157: 967-72.
10. Bergman R, Malkin L, Sabo E, Kerner H. MIB-1 monoclonal antibody 
to determine proliferative activity of Ki-67 antigen as an adjunct to the 
histopathologic differential diagnosis of Spitz nevi. J Am Acad Dermatol 
2001; 44: 500-4.
11. Vollmer RT. Use of Bayes rule and MIB-1 proliferation index to discrimi-
nate Spitz nevus from malignant melanoma. Am J Clin Pathol 2004; 
122: 499-505.
12. Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, 
Scolyer RA. Sentinel lymph node biopsy in histologically ambiguous me-
lanocytic tumors with spitzoid features (so-called atypical spitzoid tu-
mors). Ann Surg Oncol 2008; 15: 302-9.
13. Mooi WJ, Krausz T. Spitz nevus versus spitzoid melanoma: diagnostic 
difficulties, conceptual controversies. Adv Anat Pathol 2006; 13: 147-56.
14. Busam KJ, Murali R, Pulitzer M, McCarthy SW, Thompson JF, Shaw 
HM, Brady MS, Coit DG, Dusza S, Wilmott J, Kayton M, Laquaglia M, 
Scolyer RA. Atypical spitzoid melanocytic tumors with positive sentinel 
lymph nodes in children and teenagers, and comparison with histologi-
cally unambiguous and lethal melanomas. Am J Surg Pathol 2009; 33: 
1386-95.
15. Busam KJ, Pulitzer M. Sentinel lymph node biopsy for patients with di-
agnostically controversial Spitzoid melanocytic tumors? Adv Anat Pathol 
2008; 15: 253-62. 